Nigel Jones

Nigel Jones is an experienced global product developer with over 35 years in the pharmaceutical industry, specializing in regulatory strategy, de-risking development programs, and vendor oversight. Currently serving as Vice President and Head of Global Development at Endo, Nigel leads a team dedicated to the research and development of branded pharmaceuticals across all phases. Previously, Nigel held senior leadership roles at various pharmaceutical and biotech companies, including Vice President of Global Clinical Operations at Auxilium Pharmaceuticals and Managing Director at Circadian Therapeutics. Additionally, Nigel is a board member at Ton Pentre FC and involved in horse racing ownership. They received First Class Honours from the University of Southampton, where they also won the Kerkut Physiology Prize.